SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-11-034121
Filing Date
2011-02-14
Accepted
2011-02-14 09:52:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 6 dsc13ga.htm SC 13G/A 42740
  Complete submission text file 0001193125-11-034121.txt   44427
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Subject) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48083 | Film No.: 11602591
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address PPD INC 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address
ESHELMAN FREDRIC N (Filed by) CIK: 0001033409 (see all company filings)

Type: SC 13G/A